Primary Central Nervous System Lymphoma
3 competing products in clinical development for Primary Central Nervous System Lymphoma.
Pipeline by Phase
Phase 11
Phase 22
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tirabrutinib + Placebo | Ono Pharmaceutical | Phase 2 | Recruiting | 42 |
| ONO-4059 + Rituximab + Methotrexate + Procarbazine + Vincristine | Ono Pharmaceutical | Phase 1 | Active | 33 |
| Methotrexate + Ibrutinib + Temozolomide | Sun Pharmaceutical | Phase 2 | UNKNOWN | 31 |